TY - JOUR
T1 - Membrane transporters in drug development and as determinants of precision medicine
AU - Galetin, Aleksandra
AU - Brouwer, Kim L.R.
AU - Tweedie, Donald
AU - Yoshida, Kenta
AU - Sjöstedt, Noora
AU - Aleksunes, Lauren
AU - Chu, Xiaoyan
AU - Evers, Raymond
AU - Hafey, Michael J.
AU - Lai, Yurong
AU - Matsson, Pär
AU - Riselli, Andrew
AU - Shen, Hong
AU - Sparreboom, Alex
AU - Varma, Manthena V.S.
AU - Yang, Jia
AU - Yang, Xinning
AU - Yee, Sook Wah
AU - Zamek-Gliszczynski, Maciej J.
AU - Zhang, Lei
AU - Giacomini, Kathleen M.
N1 - Publisher Copyright:
© 2024, Springer Nature Limited.
PY - 2024/4/1
Y1 - 2024/4/1
N2 - The effect of membrane transporters on drug disposition, efficacy and safety is now well recognized. Since the initial publication from the International Transporter Consortium, significant progress has been made in understanding the roles and functions of transporters, as well as in the development of tools and models to assess and predict transporter-mediated activity, toxicity and drug–drug interactions (DDIs). Notable advances include an increased understanding of the effects of intrinsic and extrinsic factors on transporter activity, the application of physiologically based pharmacokinetic modelling in predicting transporter-mediated drug disposition, the identification of endogenous biomarkers to assess transporter-mediated DDIs and the determination of the cryogenic electron microscopy structures of SLC and ABC transporters. This article provides an overview of these key developments, highlighting unanswered questions, regulatory considerations and future directions.
AB - The effect of membrane transporters on drug disposition, efficacy and safety is now well recognized. Since the initial publication from the International Transporter Consortium, significant progress has been made in understanding the roles and functions of transporters, as well as in the development of tools and models to assess and predict transporter-mediated activity, toxicity and drug–drug interactions (DDIs). Notable advances include an increased understanding of the effects of intrinsic and extrinsic factors on transporter activity, the application of physiologically based pharmacokinetic modelling in predicting transporter-mediated drug disposition, the identification of endogenous biomarkers to assess transporter-mediated DDIs and the determination of the cryogenic electron microscopy structures of SLC and ABC transporters. This article provides an overview of these key developments, highlighting unanswered questions, regulatory considerations and future directions.
UR - http://www.scopus.com/inward/record.url?scp=85183051858&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/e2b3aed7-06d9-30f5-af54-c18f65c8d6af/
U2 - 10.1038/s41573-023-00877-1
DO - 10.1038/s41573-023-00877-1
M3 - Review article
AN - SCOPUS:85183051858
SN - 1474-1776
VL - 23
SP - 255
EP - 280
JO - Nature Reviews Drug Discovery
JF - Nature Reviews Drug Discovery
IS - 4
ER -